Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Mycoses|December 8, 2018
Rhodotorula infection in haematological patient: Risk factors and outcomeLeonardo Potenza, Maria N Chitasombat, Nikolay Klimko, et al.
Journal of Cellular and Molecular Medicine|July 21, 2025
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in MyelofibrosisMargherita Mirabile, Camilla Tombari, Anita Neroni, et al.
The Oncologist|September 12, 2021
Changes in Cancer Patients' and Caregivers' Disease Perceptions While Receiving Early Palliative Care: A Qualitative and Quantitative AnalysisEleonora Borelli, Sarah Bigi, Leonardo Potenza, et al.
American Journal of Hematology|July 2, 2024
Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenograftsLara Tavernari, Sebastiano Rontauroli, Ruggiero Norfo, et al.
Oncotarget|November 18, 2015
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signalingLaura Mediani, Federica Gibellini, Jessika Bertacchini, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2019
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 studyMaria Ilaria Del Principe, Giulia Dragonetti, Luisa Verga, et al.
International Journal of Molecular Sciences|September 10, 2021
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid LeukemiaFabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
Blood|December 9, 2016
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitorsPatrizia Comoli, Sabrina Basso, Giovanni Riva, et al.
British Journal of Haematology|December 20, 2015
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivationFabio Forghieri, Mario Luppi, Patrizia Barozzi, et al.
Leukemia|March 17, 2023
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse modelElisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, et al.
Pageof 12